Detalhe da pesquisa
1.
Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada.
Pharmacoeconomics
; 42(1): 69-90, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37596504